Two phase I/II clinical trials for the treatment of urinary incontinence with autologous mesenchymal stem cells.

We proposed to evaluate the safety and feasibility of adipose-derived mesenchymal stem cells to treat endoscopically urinary incontinence after radical prostatectomy in men or female stress urinary.